1-Sadock BG, Sadock VA. Kaplan and Sadock's Synopsis of psychiatry, behavioral clinical psychiatry.10th ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2007: P. 1206-17.
2-Greenhill LL, Hechtman LI. Attention-Deficit/Hyperactivity Disorder. In: Sadock BJ, Sadock VA, Ruiz P. (eds). Comprehensive Text Book of Psychiatry. 9th ed. Philadelphia: Lippincott, Williams & Wilkins 2009: 3560-72.
3-Faraone SV, Sergeant J, Gillbery C. ‘et al’. The worldwide Prevalence of ADHD: Is it an American condition? World Psychiatry 2003 Jun; 2(2): 104-13.
4-Skounti M, Philalithis A, Galanakis E. Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J pediatr 2007 Feb; 166(2): 117-23.
5-Tashakori A, Afkandeh R. prevalence of ADHD symptoms among male preschoolers based on different informants in Ahvaz city in Iran. ISRN Pediatrics 2011 july. Hindawi Publishing Corporation.‘ Available at;.
www.hidawi.com/isrn/pediatrics/2011/709653. Accessed Sep 28, 2014.
6-Anderson GM, Martin A. Neurochemistry Pharmacodynamic and biological psychiatry Spetie L, Arnold LE. Attention-Deficit/Hyperactivity Disorder. In: Martin A, Volkmar FR. Lewis's Child and Adolescent Psychiatry: A Comprehensive Textbook, 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2007: 240-3, 430-49.
7-Greydaus DE, Pratt HD, Patel DR. Attention Deficit- Hyperactivity Disorder across lifespan: the child, adolescent, and adult. Dis Mon 2007; 53: 70-131.
8-Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Research reviews 2003; 33-84.
9-Ramos BP, Arnsten AF. Adrenergic pharmacological cognition: Focus on the prefrontal cortex pharmacology & Therapeutics 2007; 113: 523-536.[PMID=17303246]
10-Mefford IN, Potter WZ. A neuroanatomical & biochemical basis for Attention Deficit Disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation. Med hypotheses 1989; 29(1):33-42. [PMID=2546021]
11-PLiszka SR, McCracken JT, Maas JW. Catecholamines in Attention Deficit- Hyperactivity Disorder: current perspectives. J AM Acad child adolesc psychiatry 1996; 35(3):264-72. [PMID=8714313]
12-Riahi F, Tashakori A, Izadi-Mazidi S, Salehi-Veisi M. Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit/ hyperactivity disorder with comorbid anxiety disorders. Iran J Psychiatry 2013; 8(4): 195-200.
13- Gualtieri CT, Golden RN, Fash JJ. New development in pediatric psychopharmacology. J Dev Bhav pediatr 1983: 202-9. [PMID=6355189]
14-Ford RE, Greenhill LL, Posner K. stimulants. In: Martin A, Scahill L, Charney DS, Leckman JF. Pediatric psychopharmacology . Newyork, oxford university press; 2003: P. 225-63.
15-Katzung BG, Masters SB, Trevor AJ. Basic and clinical pharmacology. Translated by Fatullahi AR, Sobhanian Kh. Tehran: Arjmand publication Co 2010: P. 177-204.
16-Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M. Pindolol and methylphenidate in children with attention deficit- hyperactivity disorder. Clinical efficacy and side-effects. J child psycho psychiatry 1996 Jul; 37(5): 587-95. [PMID=8807439]
17-Green WH. Child and adolescent clinical psychopharmacology. 4th ed. Philadelphia: Lippincott, Williams & Wilkins 2007: P. 319-22.
18-Spencer TJ, Wilens T, Biederman J, Weisler RH, Read SC, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in management of attention deficit/ hyperactivity disorder in adolescent patients: a 4 weeks, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2006 Feb; 28(2): 266-79. [PMID=16678648]
19-Kuperman K, Stewart MA. Use of propranolol to decrease aggressive outbursts in younger patients. Open study reveals potentially favorable outcome. Psychosomatics 1987 Jun; 28(6): 315-9. [PMID=3432546]
20-Tashakori A, Ghaderi H, Riahi F, Ghaffari M, Sepandi M. Assessment of methylphenidate and propranolol combination treatment in comparison with methylphenidate and placebo among children with Attention Deficit- Hhyperactivity Disorder. SMJ 2011; 10(1): 45-57.
21-Weiss M, Weiss G. Attention Deficit- Hyperactivity Disorder. In: Martin A, Volkmar FR. Lewis's Child and Adolescent Psychiatry: A Comprehensive Textbook, 3rd ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2002, P: 645-51.
22-Brock SE, Clinton A. Diagnosis of attention deficit/ hyperactivity disorder (AD/HD) in childhood: A review of the literaturee. The california school psychologist. J child Dev 2007; (12): 73-91.
24-Mattes JA. propranolol for adult with temper outburst & residual ADHD. J clin psychopharmacology 1986 Oct; 6(5): 299-302.
25-Mattes JA. Comparative effectiveness of carbamazepine and propranolol for rage outbursts. Neuropsychiatry clin neurosci 1990; 2(2): 159-164.[PMID=2136070]هنجاریابی و ویژگی های روان سنجی مقیاس درجه بندی کانرز - فرم
)